CSRXP: BIG PHARMA’S EGREGIOUS $158,000 PRICE TAG ON UNPROVEN ALS TREATMENT MIRRORS PRICE-GOUGING OF ADUHELM
Oct 6, 2022
Brand Name Drug Maker Amylyx Sets Price Tag For Relyvrio Between Five And 17… Read More
© 2024 CSRXP- All Rights Reserved
Updates
BIG PHARMA WATCH: BIG PHARMA HIKED PRICES FASTER THAN INFLATION ON MORE THAN 1,200 DRUGS FROM 2021-2022
Oct 4, 2022
HHS Reports Demonstrate Cost of Big Pharma Egregious Pricing Practices and… Read More
DOSE OF REALITY: NEW STUDY DEBUNKS BIG PHARMA CLAIMS THAT HIGH PRESCRIPTION DRUG PRICES ARE TIED TO R&D INVESTMENTS
Sep 29, 2022
JAMA Network Open Paper Finds “No Relationship” Between Drug Company’s… Read More
BIG PHARMA WATCH: BIOGEN TO PAY U.S. GOVERNMENT $900M FOR ANTI-COMPETITIVE KICKBACK SCHEME
Sep 27, 2022
Biogen Agrees to Settle Case Over Illegally Paying Doctors to Push Brand Name… Read More
CSRXP: AMERICAN PATIENTS COUNTING ON CONGRESS TO BUILD ON POSITIVE PROGRESS TOWARD LOWERING DRUG PRICES, NOT GO BACKWARDS
Sep 26, 2022
Lawmakers Must Put Patients First And Reject Bogus Big Pharma Rhetoric… Read More
BIG PHARMA WATCH: CEO UNDERCUTS OWN INDUSTRY’S DOOM AND GLOOM RHETORIC ON RECENT DRUG PRICING SOLUTIONS
Sep 22, 2022
Novartis Exec Calls Policy to Keep Price Hikes Below Inflation… Read More
DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR CANCER PATIENTS
Sep 20, 2022
Shining a Light on How Big Pharma is Rapidly Increasing Prices on Oncology… Read More
ICYMI: WHAT COMES NEXT AFTER MAJOR STEP FORWARD ON DRUG PRICING
Sep 19, 2022
What Comes Next After Major Step Forward on Drug Pricing Real Clear Health… Read More
BIG PHARMA WATCH: REPORT FINDS BIG PHARMA’S “PERVASIVE” PATENT ABUSE “THE ROOT OF THE DRUG PRICING CRISIS”
Sep 15, 2022
I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will… Read More
CSRXP: MODERNA MUST BE PUT ON NOTICE THAT PATIENTS, POLICYMAKERS WOULD FIND SIX-FOLD VACCINE PRICE HIKE UNCONSCIONABLE
Sep 12, 2022
Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with… Read More
BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY
Sep 9, 2022
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance… Read More
SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC
Sep 1, 2022
FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually… Read More